Advanced Fibrosis Detection for MASLD in Primary Care

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will generate generalizable data to dramatically enhance MASLD management in primary care.
Epistemonikos ID: 001c0a440d88084bf25d6757a80ee68b1896080a
First added on: Sep 09, 2025